Sebyung Kang

Sebyung Kang

Auto-generated profile, based on publicly available information

Sebyung Kang

Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Korea

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 May 2015 in Sensors
Verified
Journal Article
Open access
PDF file
HHHiep Nguyen Hoang
Hiep Nguyen Hoang
JPJeho Park
Jeho Park
SKSebyung Kang
Sebyung Kang
Moonil KimMoonil Kim
Moonil Kim
Surface plasmon resonance (SPR) is a label-free detection method which has emerged during the last two decades as a suitable and reliable platform in clinical analysis for biomolecular interactions. The technique makes it possible to measure interactions in real-time with high sensitivity and without the need of labels. This review article discusses a wide range of applications in optical-based sensors using either surface plasmon resonance (SPR) or surface plasmon resonance imaging (SPRI). Here we summarize the principles, provide examples, and illustrate the utility of SPR and SPRI through example applications from the biomedical, proteomics, genomics and bioengineering fields. In addition, SPR signal amplification strategies and surface functionalization are covered in the review.

31 October 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
JOJun Yong Oh
Jun Yong Oh
HKHan Sol Kim
Han Sol Kim
LPL. Palanikumar
L. Palanikumar
EGEun Min Go
Eun Min Go
BJBatakrishna Jana
Batakrishna Jana
Ja-Hyoung RyuJa-Hyoung Ryu
Ja-Hyoung Ryu
Targeted drug delivery using nanoparticles can minimize the side effects of conventional pharmaceutical agents and enhance their efficacy. However, translating nanoparticle-based agents into clinical applications still remains a challenge due to the difficulty in regulating interactions on the interfaces between nanoparticles and biological systems. Here, we present a targeting strategy for nanoparticles incorporated with a supramolecularly pre-coated recombinant fusion protein in which HER2-binding affibody combines with glutathione-S-transferase. Once thermodynamically stabilized in preferred orientations on the nanoparticles, the adsorbed fusion proteins as a corona minimize interactions with serum proteins to prevent the clearance of nanoparticles by macrophages, while ensuring systematic targeting functions in vitro and in vivo. This study provides insight into the use of the supramolecularly built protein corona shield as a targeting agent through regulating the interfaces between nanoparticles and biological systems.

11 September 2014 in Biomacromolecules
Verified
Journal Article
Closed access
HMHyojin Moon
Hyojin Moon
JLJisu Lee
Jisu Lee
JMJunseon Min
Junseon Min
SKSebyung Kang
Sebyung Kang

1 April 2014 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
JHJae-A Han
Jae-A Han
YKYoung Ji Kang
Young Ji Kang
CSChangsik Shin
Changsik Shin
JRJae-Sun Ra
Jae-Sun Ra
HSHyun-Hee Shin
Hyun-Hee Shin
SKSebyung Kang
Sebyung Kang

3 January 2023 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
HCHyukjun Choi
Hyukjun Choi
MYMirae Yeo
Mirae Yeo
YKYujin Kang
Yujin Kang
EKEunhee Kim
Eunhee Kim
SPSeong Guk Park
Seong Guk Park
SKSebyung Kang
Sebyung Kang
The aggressive proliferation of tumor cells often requires increased glucose uptake and excessive anaerobic glycolysis, leading to the massive production and secretion of lactate to form a unique tumor microenvironment (TME). Therefore, regulating appropriate lactate levels in the TME would be a promising approach to control tumor cell proliferation and immune suppression. To effectively consume lactate in the TME, lactate oxidase (LOX) and catalase (CAT) were displayed onto Aquifex aeolicus lumazine synthase protein nanoparticles (AaLS) to form either AaLS/LOX or AaLS/LOX/CAT. These complexes successfully consumed lactate produced by CT26 murine colon carcinoma cells under both normoxic and hypoxic conditions. Specifically, AaLS/LOX generated a large amount of H2O2 with complete lactate consumption to induce drastic necrotic cell death regardless of culture condition. However, AaLS/LOX/CAT generated residual H2O2, leading to necrotic cell death only under hypoxic condition similar to the TME. While the local administration of AaLS/LOX to the tumor site resulted in mice death, that of AaLS/LOX/CAT significantly suppressed tumor growth without any severe side effects. AaLS/LOX/CAT effectively consumed lactate to produce adequate amounts of H2O2 which sufficiently suppress tumor growth and adequately modulate the TME, transforming environments that are favorable to tumor suppressive neutrophils but adverse to tumor-supportive tumor-associated macrophages. Collectively, these findings showed that the modular functionalization of protein nanoparticles with multiple metabolic enzymes may offer the opportunity to develop new enzyme complex-based therapeutic tools that can modulate the TME by controlling cancer metabolism. Graphical Abstract

22 July 2019 in Biotechnology and Bioengineering
Verified
Journal Article
Closed access
PDF file
HKHansol Kim
Hansol Kim
HCHyukjun Choi
Hyukjun Choi
YBYoonji Bae
Yoonji Bae
SKSebyung Kang
Sebyung Kang